Source: Eur Respir J 2010; 35: 812-820
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dehnert C., Luks A. M., Schendler G., Menold E., Berger M. M., Mairbaurl H., Faoro V., Bailey D. M., Castell C., Hahn G., Vock P., Swenson E. R., Bartsch P.. No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m. Eur Respir J 2010; 35: 812-820

Member's Comments

No comment yet.

Related content which might interest you: Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases? Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 Pulmonary vascular response patterns during exercise in interstitial lung disease Source: Eur Respir J 2015; 46: 738-749 Year: 2015 Exercise tolerance in interstitial and chest wall disorders Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease Year: 2005 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 The effect of exercise in the patients with the diagnosis of interstitial lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 372s Year: 2006 The difference of lung mechanics and chest kinematics in pulmonary rehabilitation of interstitial lung diseases versus idiopathic pulmonary fibrosis Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases Year: 2019 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same? Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Interstitial fibrosis with a nodule Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session Year: 2007 Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019 Year: 2020 Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006